kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30



